Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Drug Discovery Today|September 8, 2001
Effective decision-making: progressing compounds through clinical developmentC A. Shillingford, C W. VoseBiomedical Mass Spectrometry|January 1, 1978
Electron impact mass spectra of 1-methyl-oestra-1,3,5(10)-trienes having intact and 13,17-seco-D-ring structuresC W Vose, M M CoombsCancer Research|February 1, 1975
The relationship between metabolism, DNA binding, and carcinogenicity of 15,16-dihydro-11-methylcyclopenta(alpha)phenanthren-17-one in the presence of a microsomal enzyme inhibitorM M Coombs, T S Bhatt, C W VoseBiomedical Mass Spectrometry|April 1, 1984
Identification of a plasma metabolite of 5-(2-bromo-E-ethenyl)-2'-deoxyuridineY Robinson, N Gerry, R D Brownsill, et al.Cancer Research|March 1, 1980
Mutagenic and carcinogenic metabolites of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-oneM M Coombs, T S Bhatt, A M Kissonerghis, et al.Journal of Chromatography|June 1, 1978
Application of ion-exchange and lipophilic-gel chromatography to the purification and group fractionation of steroidal spirolactones, isolated from biological fluidsD R Boreham, C W Vose, R F Palmer, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1981
The metabolism of canrenone in vitro by rat liver preparationsD R Boreham, C W Vose, R F Palmer, et al.Biomedical Mass Spectrometry|September 1, 1978
Electron impact and chemical ionization mass spectrometry of steroidal spirolactonesD R Boreham, G C Ford, N J Haskins, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1979
Identification of some human urinary metabolites of orally administered potassium canrenoate by stable isotope-labeling techniquesC W Vose, D R Boreham, G C Ford, et al.Pageof 3